Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Adrenocortical Carcinoma × Blood Specimen Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Neoplasms 11 Carcinoma, Non-Small-Cell Lung 9 Lung Neoplasms 8 Colorectal Neoplasms 8 Prostatic Neoplasms 7 Melanoma 7 Pancreatic Neoplasms 4 Neoplastic Cells, Circulating 4 Neoplasm Metastasis 4 Kidney Neoplasms 4 Recurrence 3 Leukemia 3 Hematologic Neoplasms 3 Head and Neck Neoplasms 3 Glioblastoma 3 Carcinoma, Renal Cell 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Ovarian Neoplasms 2 Myeloproliferative Disorders 2 Liver Diseases 2 Leukemia, Myeloid, Acute 2 Glioma 2 Fibrosis 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Colonic Neoplasms 2

Interventions

cabazitaxel 1 Sorafenib 1 Ritonavir 1 Radiotherapy 1 Paclitaxel 1 Nivolumab 1 Mitotane 1 Lymph Node Excision 1 Indinavir 1 IPI-549 1 Blood Specimen Collection 1 Adrenalectomy 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05660889 2022-12-21

AVS for ACC

Erasmus Medical Center

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡